Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

被引：0
|
作者：
Putra, J. [1 ]
Schiano, T. [2 ]
Fiel, M. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Pathol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
150
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [41] Early Experience with Salvage Direct-Acting Antiviral (DAA) Therapy in Liver Transplant Recipients
    Yoon, Bo Hyung
    Halegoua-DeMarzio, Dina L.
    Fenkel, Jonathan M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1301 - S1301
  • [42] 'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant
    Fabrizi, Fabrizio
    Alonso, Cristina
    Palazzo, Ana
    Anders, Margarita
    Virginia Reggiardo, Maria
    Cheinquer, Hugo
    Videla Zuain, Maria Grazia
    Figueroa, Sebastian
    Mendizabal, Manuel
    Silva, Marcelo
    Ridruejo, Ezequiel
    ANNALS OF HEPATOLOGY, 2021, 25
  • [43] RELAPSING HCV ASSOCIATED GLOMERULONEPHRITIS DESPITE SUSTAINED VIROLOGIC RESPONSE (SVR) TO DIRECT-ACTING ANTIVIRALS (DAA)
    Scuorzo, Joseph
    Hanna, Wael
    Chong, Grace
    Fleszler, Frederick
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 731 - 732
  • [44] Liver fibrosis regression in HIV-HCV co-infected individuals after sustained virologic response with HCV direct-acting antivirals
    Arias, Ana
    Lledo, Gemma
    Trevino, Ana
    Benitez-Gutierrez, Laura
    Carrasco, Itziar
    Cuervas-Mons, Valentin
    De Mendoza, Carmen
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [45] Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy
    Flemming, Jennifer A.
    Kim, W. Ray
    Brosgart, Carol L.
    Terrault, Norah A.
    HEPATOLOGY, 2017, 65 (03) : 804 - 812
  • [46] What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou, George N.
    Feld, Jordan J.
    GASTROENTEROLOGY, 2019, 156 (02) : 446 - +
  • [47] Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents
    Cholankeril, G.
    Yoo, E. R.
    Hu, M.
    Gadiparthi, C.
    Khan, M. A.
    Perumpail, R. B.
    Bonham, C. A.
    Ahmed, A.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (12) : 1194 - 1195
  • [48] HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
    Rice, Donald P., Jr.
    Faragon, John J.
    Banks, Sarah
    Chirch, Lisa M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2016, 4 (03) : 234 - 240
  • [49] Direct-acting antiviral agents are not associated with an increased risk of hepatocellular carcinoma recurrence in liver transplant recipients with hepatitis C
    Tse, Chung Sang
    Yang, Judong
    Mousa, Omar
    Pungpapong, Surakit
    Keaveny, Andrew
    Nelson, Kevin
    Bashar, Aqel
    Dickson, Rolland
    Vargas, Hugo E.
    Gores, Gregory
    Roberts, Lewis
    Leise, Michael
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E571 - E571
  • [50] Management of acute HCV infection in the era of direct-acting antiviral therapy
    Martinello, Marianne
    Hajarizadeh, Behzad
    Grebely, Jason
    Dore, Gregory J.
    Matthews, Gail V.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (07) : 412 - 424
12345